ICU Medical (NASDAQ:ICUI) Sets New 12-Month High at $160.00

Shares of ICU Medical, Inc. (NASDAQ:ICUI) reached a new 52-week high on Thursday . The company traded as high as $160.00 and last traded at $158.80, with a volume of 47685 shares traded. The stock had previously closed at $157.30.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. KeyCorp raised their price target on shares of ICU Medical from $136.00 to $147.00 and gave the stock an “overweight” rating in a research report on Thursday, August 8th. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research note on Thursday, August 8th. Finally, Raymond James raised their target price on ICU Medical from $135.00 to $158.00 and gave the company an “outperform” rating in a research note on Thursday, August 8th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $138.33.

ICU Medical Trading Up 3.0 %

The business has a fifty day moving average of $130.05 and a 200-day moving average of $112.33. The stock has a market capitalization of $3.99 billion, a price-to-earnings ratio of -66.76 and a beta of 0.69. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.61 and a quick ratio of 1.09.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.56. The firm had revenue of $596.50 million for the quarter, compared to analysts’ expectations of $556.64 million. ICU Medical had a positive return on equity of 5.38% and a negative net margin of 2.63%. ICU Medical’s revenue was up 8.6% on a year-over-year basis. During the same quarter last year, the business posted $1.58 EPS. On average, equities analysts anticipate that ICU Medical, Inc. will post 3.5 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, COO Christian B. Voigtlander sold 12,539 shares of ICU Medical stock in a transaction dated Thursday, May 30th. The stock was sold at an average price of $103.95, for a total value of $1,303,429.05. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other ICU Medical news, COO Christian B. Voigtlander sold 12,539 shares of the firm’s stock in a transaction dated Thursday, May 30th. The stock was sold at an average price of $103.95, for a total transaction of $1,303,429.05. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Virginia Ruth Sanzone sold 2,050 shares of the firm’s stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $144.11, for a total value of $295,425.50. Following the sale, the vice president now owns 4,482 shares of the company’s stock, valued at $645,901.02. The disclosure for this sale can be found here. In the last quarter, insiders have sold 26,589 shares of company stock valued at $3,471,335. 6.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On ICU Medical

A number of institutional investors have recently bought and sold shares of the business. Truist Financial Corp acquired a new stake in ICU Medical during the 2nd quarter worth about $310,000. Creative Planning boosted its position in ICU Medical by 75.5% during the 2nd quarter. Creative Planning now owns 3,906 shares of the medical instruments supplier’s stock worth $464,000 after acquiring an additional 1,680 shares during the period. Lighthouse Investment Partners LLC boosted its position in ICU Medical by 484.4% during the 2nd quarter. Lighthouse Investment Partners LLC now owns 62,826 shares of the medical instruments supplier’s stock worth $7,461,000 after acquiring an additional 52,076 shares during the period. Millennium Management LLC boosted its position in ICU Medical by 327.8% during the 2nd quarter. Millennium Management LLC now owns 136,070 shares of the medical instruments supplier’s stock worth $16,158,000 after acquiring an additional 104,264 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in ICU Medical during the 2nd quarter worth about $70,000. 96.10% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.